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A B S T R A C T
Molecular methods are fundamental tools for the diagnosis of viral infections. While interpretation of
results is straightforward for unvaccinated animals, where positivity represents ongoing or past
infections, the presence of vaccine virus in the tissues of recently vaccinated animals may mislead
diagnosis.
In this study, we investigated the interference of RHDV2 vaccination in the results of a RT-qPCR for
RHDV2 detection, and possible associations between mean Cq values of ﬁve animal groups differing in
age, vaccination status and origin (domestic/wild).
Viral sequences from vaccinated rabbits that died of RHDV2 infection (n = 14) were compared with the
sequences from the commercial vaccines used in those animals. Group Cq means were compared through
Independent t-test and One-way ANOVA.
We proved that RHDV2 vaccine-RNA is not detected by the RT-qPCR as early as 15 days post-
vaccination, an important fact in assisting results interpretation for diagnosis.
Cq values of vaccinated and non-vaccinated infected domestic adults showed a statistically signiﬁcant
difference (p < 0.05), demonstrating that vaccination-induced immunity reduces viral loads and delays
disease progression. Contrarily, in vaccinated young rabbits higher viral loads were registered compared
to non-vaccinated kittens. No signiﬁcant variation (p = 0.3824) was observed between viral loads of non-
vaccinated domestic and wild RHDV2-victimised rabbits. Although the reduced number of vaccinated
young animals analysed hampered a robust statistical analysis, this occurrence suggests that passively
acquired maternal antibodies may inhibit the active immune response to vaccination, delaying
protection and favouring disease progression.
Our ﬁnding emphasises the importance of adapting kitten RHDV2 vaccination schedules to circumvent
this interference phenomenon.
© 2016 Elsevier B.V. All rights reserved.
1. Introduction
Six years after its emergence in Europe, rabbit haemorrhagic
disease virus 2 (RHDV2) continues to provoke severe economic
losses in the industry, to cause great concerns on the conservation
of diminished wild rabbit populations and dependent endangered
carnivore species, and to affect deeply the cinegetic activity and
tourism associated income of some countries.
RHDV2, reported for the ﬁrst time in 2010 (Le Gall-Reculé et al.,
2011a), is classiﬁed within the Lagovirus genus (Le Gall-Reculé
et al., 2011a) along with the close genetically related RHDV,
European brown hare syndrome virus (EBHSV) and non-patho-
gentic lagoviruses (Le Gall-Reculé et al., 2011b). Since its
emergence in France (Le Gall-Reculé et al., 2011a), RHDV2 quickly
spread throughout neighbouring European countries (Dalton et al.,
2012; Abrantes et al., 2013; Le Gall-Reculé et al., 2013; Baily et al.,
2014; Westcott et al., 2014)(information on the FLI, 10|21|2013),
replacing the previously circulating classical strains (Lopes et al.,
2015). RHDV2 was registered outside Europe in Australia (Hall
et al., 2015).* Corresponding author.
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